Updated: Nov 21, 2022 19:07 IST
Study suggests adverse affects of antibody drug conjugates- cancer therapies
ADCs, or antibody drug conjugates, are a class of complicated cancer treatments that have undergone extensive testing in clinical studies. The study explained the potential hazards related to these drugs.
Read more
हिंदी खबर